Heptavalent Pneumococcal Conjugate Vaccine
"Heptavalent Pneumococcal Conjugate Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pneumococcal vaccine which contains 7 pneumococcal serotypes (6B, 14, 19F, 23F, 18C, 4, 9V), each conjugated individually to the outer membrane protein complex of NEISSERIA MENINGITIDIS.
| Descriptor ID |
D000069443
|
| MeSH Number(s) |
D20.215.894.135.750.600.500
|
| Concept/Terms |
Heptavalent Pneumococcal Conjugate Vaccine- Heptavalent Pneumococcal Conjugate Vaccine
- 7-valent PncOMPC vaccine
- 7 valent PncOMPC vaccine
- PncOMPC vaccine, 7-valent
- PNCRM7
- Seven-Valent Pneumococcal PS-Meningococcal OMPC Conjugate Vaccine
- Seven Valent Pneumococcal PS Meningococcal OMPC Conjugate Vaccine
|
Below are MeSH descriptors whose meaning is more general than "Heptavalent Pneumococcal Conjugate Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Heptavalent Pneumococcal Conjugate Vaccine".
This graph shows the total number of publications written about "Heptavalent Pneumococcal Conjugate Vaccine" by people in this website by year, and whether "Heptavalent Pneumococcal Conjugate Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 10 | 6 | 16 |
| 2018 | 9 | 4 | 13 |
| 2019 | 3 | 2 | 5 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Heptavalent Pneumococcal Conjugate Vaccine" by people in Profiles.
-
Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians. Clin Infect Dis. 2020 06 10; 70(12):2607-2615.
-
Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up. Vaccine. 2019 08 14; 37(35):5016-5024.
-
Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. Vaccine. 2019 07 26; 37(32):4491-4498.
-
Hospital-onset adult invasive pneumococcal disease in Israel: Sicker patients, different pathogens. Int J Infect Dis. 2019 Aug; 85:195-202.
-
Making sense of differences in pneumococcal serotype replacement. Lancet Infect Dis. 2019 06; 19(6):e213-e220.
-
Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media. BMC Infect Dis. 2019 Jan 11; 19(1):44.
-
Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia. Sci Rep. 2018 11 16; 8(1):16969.
-
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. 2018 10 08; 36(42):6307-6313.
-
The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis. Vaccine. 2018 09 18; 36(39):5832-5845.
-
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides. mSphere. 2018 08 08; 3(4).